Moreover, PLAU, as a prognostic marker, was found to promote CAFs conversion and the proliferation and migration of esophageal squamous cell carcinoma via the uPAR/Akt/NF-κB/IL8 pathway39. Here, AKT1 is linked to esophageal squamous cell carcinoma.